Compounds that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.
本文披露了能够作为
嘌呤受体拮抗剂的化合物、包括这些化合物的药物组成物,以及制备这些化合物的方法。这些化合物和组成物可用于治疗或预防与
嘌呤受体过度功能相关的疾病。